Search results
Author(s):
Marielle Scherrer-Crosbie
Added:
1 year ago
ACC.23/WCC — In this succinct late-breaking science interview, Investigator, Dr Marielle Scherrer-Crosbie (Hospital of the University of Pennsylvania, US) discusses the results from the STOP-CA trial (Massachusetts General Hospital). This randomized phase II trial aims to investigate whether atorvastatin, a commonly prescribed statin drug for reducing cholesterol levels, can protect the heart…
View more
Author(s):
Mark Sweeney
,
Angela Yiu
,
Alexander Lyon
Added:
3 years ago
Cancer and the anti-cancer treatments prescribed by oncologists have long been known to have significant effects on muscle, causing a catabolic muscle wasting state and resulting in widespread and progressive atrophy of most muscle groups.1 This process contributes significantly to the cancer cachexia seen in up to 80% of all patients with cancer, resulting in progressive weight loss, loss of…
View more
Author(s):
Martin Nicol
,
Mathilde Baudet
,
Alain Cohen-Solal
Added:
3 years ago
Advances in the early detection and treatment of cancer have improved overall survival in cancer patients. Nevertheless, cardiovascular diseases appear as the major cause of morbidity and mortality among cancer survivors.1 Left ventricular (LV) dysfunction and/or heart failure are the most common cardiovascular complications after administration of chemotherapies. The term ‘cardiotoxicity’ is…
View more
Marielle Scherrer-Crosbie
Job title: Director
Author
Roxy Senior
Author
Barry H Greenberg
Job title: Professor of Medicine and Director of the Advanced Heart Failure Treatment Program
Author
Author(s):
John GF Cleland
Added:
10 months ago
ESC-HFA 2023 – Prof John Cleland (University of Glasgow, Glasgow, UK) discusses the findings from a study that looked at the diagnostic of heart failure in a cohort of 1.1 million people using the NHS EMR database.
Finding presented at Heart Failure 2023, showed that more people treated with LD than receive diagnosis of heart failure, this disparity was greater in women compared to men.
…
View more
Author(s):
Carine E Hamo
,
Michelle W Bloom
Added:
3 years ago
Heart disease and cancer are the two leading causes of death, together accounting for almost 50 % of deaths in the US.1 Unfortunately, the tremendous success in improving cancer survival is often attenuated by downstream cardiovascular complications from cancer therapy. Acute cardiac toxicity may limit the ability to use life-saving cancer therapy and chronic toxicity limits overall survival. As…
View more
Heart Failure and Cancer
Author(s):
Alessandra Cuomo
,
Alessio Rodolico
,
Amalia Galdieri
,
et al
Added:
3 years ago
Article
Author(s):
Edoardo Bertero
,
Pietro Ameri
,
Christoph Maack
Added:
3 years ago
Heart failure (HF) and cancer represent two major causes of morbidity and mortality in developed countries.1,2 The prevalence of these conditions is growing as the age of the population and the burden of shared risk factors, such as diabetes and obesity, are constantly increasing. In past decades, the field of cardio-oncology has predominantly focused on prevention and treatment of cardiovascular…
View more